SEC Tracker
Get the app

Gamida Cell

Effective January 1, 2022, Gamida Cell Ltd. will begin

Form
8-K
Filed
Period
Importance
Routine
Document
8-K
  • Makes a Regulation FD disclosure (7.01)

Not explained yet; the original is on EDGAR.

View on EDGAR

Open in the app

Get an email when Gamida Cell files

Only major filings: results, leadership changes, listing notices and other major events, each with the plain-English summary when we have one or the key facts and the EDGAR link. Routine insider filings never email. Confirm once; unsubscribe in one click.

Similar companies

Same SIC code (2836) and public float not reported.

  1. Adaptimmune Therapeutics ADAP
  2. Adverum Biotechnologies ADVM
  3. AgomAb Therapeutics AGMB
  4. Alvotech ALVO
  5. Argenx ARGX

Data on this page was fetched . The filing on SEC.gov is the record.